HIV and drug allergy

Area of Science:

• Pharmacology
• Immunology
• Infectious Diseases

Background:

• Numerous antiretroviral drugs are approved for HIV treatment, with varying associations with allergic and hypersensitivity reactions.
• Key drug classes frequently implicated include abacavir, nonnucleoside reverse transcriptase inhibitors, and amprenavir.
• Trimethoprim-sulfamethoxazole, crucial for opportunistic infection management in HIV, also presents a notable risk of adverse reactions.

Purpose of the Study:

• To provide a comprehensive overview of drug-related allergic and hypersensitivity reactions in individuals with HIV.
• To discuss the underlying mechanisms (pathogenesis) of these adverse drug reactions.
• To outline current management strategies for managing hypersensitivity reactions to antiretroviral and related medications.

Main Methods:

• Literature review of FDA-approved antiretroviral drugs and their associated adverse reactions.
• Analysis of reported hypersensitivity and allergic reactions linked to specific drug classes.
• Examination of the pathogenesis and clinical management of drug-induced hypersensitivity.

Main Results:

• Abacavir, nonnucleoside reverse transcriptase inhibitors, and amprenavir are frequently associated with hypersensitivity.
• Trimethoprim-sulfamethoxazole use in HIV patients is linked to significant adverse reactions.
• Understanding reaction patterns is crucial for effective patient management.

Conclusions:

• Hypersensitivity reactions are a significant concern with several antiretroviral agents and trimethoprim-sulfamethoxazole in HIV management.
• Further research into drug-specific hypersensitivity mechanisms can guide safer prescribing practices.
• Effective management strategies are essential to mitigate the impact of these reactions on HIV treatment adherence and outcomes.